Share class: Virbac

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 8,458,000 4,036,907 ( 47.73 %) 88,281 ( 1.044 %) 47.73 %

Major shareholders: Virbac

NameEquities%Valuation
50.09 %
4,203,226 50.09 % 1 589 M €
Financière de l'Échiquier SA
1.604 %
134,570 1.604 % 51 M €
Amundi Asset Management SASU (Investment Management)
0.762 %
63,938 0.762 % 24 M €
BNP Paribas Asset Management Belgium SA
0.7176 %
60,208 0.7176 % 23 M €
Société Virbac SA Employee Stock Ownership Plan
0.5724 %
48,029 0.5724 % 18 M €
Joh. Berenberg, Gossler & Co. KG (Investment Management)
0.481 %
40,360 0.481 % 15 M €
Montpensier Arbevel
0.3139 %
26,340 0.3139 % 10 M €
Inocap Gestion SAS
0.2293 %
19,243 0.2293 % 7 M €
Virbac SA
0.1915 %
16,066 0.1915 % 6 M €
Capricorn Venture Partners NV (Investment Management)
0.1728 %
14,500 0.1728 % 5 M €
░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░

Breakdown by shareholder type

Individuals50.21%
Institutional5.99%
Other0.57%
Virbac SA0.19%
Unknown43.04%

Based on 1000 largest holdings

Geographical origin of shareholders

Individuals
50.22%
France
4.94%
Belgium
0.96%
Germany
0.56%
Finland
0.12%
United Kingdom
0.1%
Ireland
0.03%
Switzerland
0.02%
Luxembourg
0.01%

Based on 1000 largest holdings

Logo Virbac
Virbac specializes in the research, production and marketing of veterinary medicines. Net sales break down by family of products as follows: - pet medications (61.6%): pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications (38.4%): pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: Europe (40.8%), Latin America (15.9%), North America (13%), India/Africa/Middle East (12.5%), East Asia (10.1%) and Pacific (7.7%).
Employees
6,365
Calendar
More about the company